Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Study of Reducing Adverse Effects After Radiofrequency Ablation Combined With Sclerotherapy

NCT05654233 is registered in ClinicalTrials.gov with Chengdu University of Traditional Chinese Medicine as lead sponsor.

NCT NCT05654233
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05654233 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Study of Reducing Adverse Effects After Radiofrequency Ablation Combined With Sclerotherapy
Lead sponsor
Chengdu University of Traditional Chinese Medicine
Phase
Not applicable
Overall status
Unknown status
Start date
February 1, 2023
Completion date
September 1, 2023
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

varicose veins of lower limb, vascular diseases, peripheral, venous insufficiency of leg